ARCA biopharma Inc (ABIO)
3.38
+0.13
(+4.00%)
USD |
NASDAQ |
Apr 19, 16:00
3.38
0.00 (0.00%)
After-Hours: 20:00
ARCA biopharma Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.002M |
| December 31, 2021 | -0.007M |
| September 30, 2021 | -0.014M |
| June 30, 2021 | -0.016M |
| March 31, 2021 | -0.006M |
| December 31, 2020 | -0.013M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.003M |
| March 31, 2020 | -0.003M |
| December 31, 2019 | -0.002M |
| September 30, 2019 | -0.002M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.003M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 3.049M |
| December 31, 2017 | 4.749M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.932M |
| June 30, 2017 | 6.101M |
| March 31, 2017 | 3.008M |
| December 31, 2016 | 3.148M |
| September 30, 2016 | -2.548M |
| June 30, 2016 | -11.81M |
| March 31, 2016 | -5.202M |
| December 31, 2015 | -0.002M |
| September 30, 2015 | -0.002M |
| June 30, 2015 | -0.005M |
| March 31, 2015 | -0.002M |
| December 31, 2014 | -0.014M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | -0.005M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.004M |
| September 30, 2013 | -0.011M |
| June 30, 2013 | -0.008M |
| March 31, 2013 | -0.009M |
| December 31, 2012 | 0.001M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | -0.001M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.005M |
| September 30, 2011 | 0.001M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.016M
Minimum
Jun 2021
--
Maximum
Jun 2019
-0.0036M
Average
-0.002M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Shockwave Medical Inc | -242.26M |
| Asensus Surgical Inc | 7.427M |
| Glaukos Corp | -12.92M |
| Helius Medical Technologies Inc | -0.003M |
| Perspective Therapeutics Inc | -0.089M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.056M |
| Free Cash Flow | -5.014M |
| Free Cash Flow Per Share (Quarterly) | -0.0732 |
| Free Cash Flow Yield | -10.29% |